Danahy Kevin Patrick
Pulse Biosciences, Inc. · Chief Commercial Officer
Danahy Kevin Patrick is listed in filings as Chief Commercial Officer at Pulse Biosciences, Inc.. This profile follows SEC Form 4 activity through Feb 23, 2026, including sale activity and purchase activity. Recent filings connect the profile to Pulse Biosciences, Inc. (PLSE). The current snapshot covers public activity from Jul 9, 2024 to Feb 23, 2026. Reported amounts are shown as $118.2K to $472.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $473k20k shares | SellFeb 17, 2026 | $23.63 | $28.96 | |
| $471k20k shares | SellFeb 13, 2026 | $23.53 | $28.96 | |
| $467k20k shares | SellFeb 12, 2026 | $23.37 | $28.96 | |
| $504k20k shares | SellFeb 11, 2026 | $25.20 | $28.96 | |
| $470k20k shares | SellFeb 10, 2026 | $23.52 | $28.96 | |
| $429k20k shares | SellFeb 9, 2026 | $21.45 | $28.96 | |
| $85k4.6k shares | SellOct 2, 2025 | $18.53 | $28.96 | |
| $7.4k400 shares | SellSep 19, 2025 | $18.48 | $28.96 | |
| $370k20k shares | SellSep 18, 2025 | $18.49 | $28.96 | |
| $3.6k325 shares | BuyJul 3, 2024 | $11.00 | $28.96 |